Patent Grant
11298235
There are a variety of conditions and diseases that impair the integrity and function of human joints. Among these joint conditions and diseases are arthroses, chondromalacia patella, isolated chondral defect, juvenile idiopathic arthritis, ligamentous deficiency arthroses, osteoarthritis (degenerative arthritis or degenerative joint disease), osteonecrosis, osteochondritis dissecans, patellar instability, post-ligamentous injury arthritis, post-meniscectomy arthritis, post-meniscectomy arthroses, post-traumatic arthritis, rheumatoid arthritis and septic arthritis. The incidence of arthritides alone in the United States exceeds 20%, with higher rates among women as compared to men. Treatment of joint conditions and diseases includes surgery and the administration of therapeutic agents. However, none of these treatments ameliorate all of the joint conditions and diseases.
Therefore, there is a need for a new method for ameliorating joint conditions and diseases.
According to one embodiment of the present invention, there is provided a device for ameliorating joint conditions and diseases. The device comprises a) a first section comprising a joint-ward end, an opposing mating end, and a lateral wall extending between the joint-ward end and the mating end, where the first section further comprises a peripheral column partially forming the lateral wall of the first section, a central column, and three or more than three struts, each strut extending between and connecting the peripheral column and the central column, and each strut thereby supporting the central column, where the joint-ward end further comprises a plurality of fenestrations, where each fenestration is formed by a confluence of the peripheral column, the central column and two adjacent struts of the three or more than three struts, and where the first section further comprises a central aperture within and formed by the central column, and configured to mate with a driver, b) a second section comprising a mating end, an opposing leading end, and a lateral wall extending between the mating end and the leading end, where the lateral wall of the second section comprises threads.
In one embodiment, the device further comprises an axial length, and the axial length is between 5 mm and 30 mm. In another embodiment, the device further comprises an axial length, and the axial length is between 5 mm and 20 mm. In another embodiment, the device further comprises an axial length, and the axial length is between 8 mm and 16 mm. In one embodiment, the first section further comprises a diameter between 5 mm and 30 mm. In another embodiment, the first section further comprises a diameter between 5 mm and 20 mm. In another embodiment, the first section further comprises a diameter between 8 mm and 16 mm. In another embodiment, the first section further comprises an axial length between 1 mm and 2 mm.
In one embodiment, each fenestration comprises a pear or teardrop shape. In another embodiment, one or more than one fenestration comprises a different size, different shape or both a different size and a different shape than one or more than one other fenestration.
In one embodiment, the central aperture comprises a six-pointed star shape. In another embodiment, the central aperture is round and comprises threads. In one embodiment, the peripheral column comprises one or more than one notch.
In one embodiment, the joint-ward end comprises a convex profile as seen on a cross-sectional, lateral perspective view. In another embodiment, the joint-ward end comprises a concave profile as seen on a cross-sectional, lateral perspective view. In another embodiment, the joint-ward end comprises a straight profile as seen on a cross-sectional, lateral perspective view. In one embodiment, the joint-ward end comprises a radius of curvature of between 20 mm and 50 mm. In another embodiment, the joint-ward end comprises a radius of curvature of between 15 mm and 45 mm. In another embodiment, the lateral wall of the first section comprises a generally convex profile as seen on a cross-sectional, lateral perspective view.
In one embodiment, the second section further comprises an axial length between 5 mm and 30 mm. In another embodiment, the second section further comprises an axial length between 5 mm and 20 mm. In another embodiment, the second section further comprises an axial length between 6 mm and 15 mm. In one embodiment, the lateral wall of the second section is generally cylindrical. In another embodiment, the lateral wall of the second section is generally conical, tapering between the mating end and the leading end. In one embodiment, the lateral wall of the second section tapers between 0.2 degrees and 15 degrees. In another embodiment, the lateral wall of the second section tapers between 1 degrees and 5 degrees. In another embodiment, the lateral wall of the second section tapers between 1 degrees and 3 degrees.
In one embodiment, the mating end of the first section and the mating end of the second section mate by a biocompatible adhesive. In another embodiment, the mating end of the first section and the mating end of the second section mate by a mating mechanism that is reversible. In another embodiment, the mating end of the first section and the mating end of the second section mate by a reversible twist locking mechanism. In another embodiment, the first section and the second section are made as a unified whole.
In one embodiment, the leading end comprises a scalloped edge. In another embodiment, the leading end comprises bevels. In another embodiment, the leading end comprises both a scalloped edge and bevels.
In one embodiment, the lateral wall of the second section further comprises a plurality of fenestrations between the threads. In another embodiment, the device further comprises a plurality of fenestrations formed by a confluence of the mating end of the first section and the mating end of the second section. In one embodiment, the device further comprises an insert, where the insert comprises a base and three or more than three extensions connected to the base and arranged radially around the base, and where each of the three or more than three extensions is configured to fit within a corresponding fenestration of the joint-ward end of first section of the device. In one embodiment, the insert further comprises porous biological material impregnated with matrix-promoting substances or serves as a scaffold for progenitor cells, or comprises both porous biological material impregnated with matrix-promoting substances and serves as a scaffold for progenitor cells.
According to another embodiment of the present invention, there is provided a method for ameliorating a joint condition or disease in a patient. The method comprises a) identifying a patient with a joint condition or disease that is suitable for treatment by the method, where the joint comprises a bone with a surface comprising a defect caused by the joint condition or disease, b) accessing the joint, c) placing a guidepin within the center of the defect, d) creating a space in the defect of the bone, e) providing a first device according to the present invention, f) attaching the first device to a driver by mating the distal end of the driver with the central aperture of the first device, and g) screwing the first device into the space using the driver until the joint-ward end of the first device forms a shape that substantially recreates the shape of a normal articulation surface on the bone after implantation.
In one embodiment, the joint is a diarthrodial joint. In another embodiment, the joint is selected from the group consisting of an acetabulofemoral joint, an acromioclavicular joint, a femoropatellar joint, a femorotibial joint, a glenohumeral joint, a humeroradial joint, a humeroulnar joint, an interphalangeal joint, a metacarpal joint, a radioulnar joint and a talocrural joint. In one embodiment, the patient is a human. In one embodiment, the patient is a non-human animal. In one embodiment, the joint condition and disease is selected from the group consisting of arthroses, chondromalacia patella, isolated chondral defect, juvenile idiopathic arthritis, ligamentous deficiency arthroses, osteoarthritis (degenerative arthritis or degenerative joint disease), osteonecrosis, osteochondritis dissecans, patellar instability, post-ligamentous injury arthritis, post-meniscectomy arthritis, post-meniscectomy arthroses, post-traumatic arthritis, rheumatoid arthritis and septic arthritis.
In one embodiment, identifying the patient comprises diagnosing the patient with a joint condition and disease. In another embodiment, diagnosing the patient comprises performing one or more than one of action selected from the group consisting of performing a physical examination, performing a non-invasive imaging examination and performing arthroscopy. In one embodiment, identifying the patient comprises consulting patient records to determine if the patient has a joint condition or disease suitable for treatment by the method. In one embodiment, accessing the joint is accomplished by arthroscopy. In one embodiment, the joint is accomplished by an open surgical procedure.
In one embodiment, the surface of the bone comprises one or more than one abnormality, and the method further comprises using a burr, or a suction shaver, or both a burr and a suction shaver to remove some or all of the one or more than one abnormality thereby creating a smoother articulation surface. In one embodiment, the method further comprises creating one or more than one vascular channel in the bone deep to the space using a drill bit guide positioned over the guidepin and a drill bit passed within the drill bit guide. In another embodiment, the method further comprises injecting a biological material into the first device. In one embodiment, the method further comprises placing an insert in the first device. In one embodiment, the method further comprises placing one or more than one additional device in the defect.
According to yet another embodiment, there is provided a method of facilitating cartilage regrowth and preventing bone overgrowth to a damaged bone at a treatment site within a body joint to promote healing. The method comprises providing a device having a first section comprising a joint-ward end having an inner surface and an outer surface and fenestrations between the inner and outer surfaces and a second section comprising an opposing leading end and a lateral wall extending between the joint-ward end and the leading end. The leading end is penetrated into the bone to a depth to substantially position: 1) the joint-ward end in a cartilage zone; wherein the outer surface of the joint-ward end is configured to facilitate cartilage regrowth; and 2) the second section in the bone; wherein the inner surface of the joint-ward end is configured to prevent bone overgrowth into the cartilage zone within the body joint when the device is positioned at the treatment site.
According to other embodiments, the device is positioned and configured to provide active or passive dampening support to the bone at the treatment site so as to dissipate and dampen shock within the bone to promote healing. The second section includes fenestrations, the fenestrations are configured to promote osseointegration of the second section at the treatment site. The joint-ward end is substantially positioned at a transition area between a cartilage layer and a bone layer such that cartilage can grow through, around and over the fenestrations in the joint-ward end. The cartilage is articular cartilage and healing includes mitigating bone hypertrophy. The fenestrations promote intracellular nutrient transmission. The transition area is located substantially in a cortical bone base plate or located substantially between cancellous bone and a cartilage zone. The device inhibits bone growth into a cartilage zone when the device is positioned at the treatment site. The device also prevents bone fracture when the device is positioned at the treatment site. The body joint may be a knee and the treatment site may include a subchondral lesion. Mitigating bone hypertrophy may include preventing trabecular thickening of the cancellous bone, for example. A thickness of cartilage regrowth at the treatment site is substantially uniform after healing and/or is substantially the same as a thickness of healthy cartilage adjacent the treatment site after healing. The device is made of titanium and at least the outer surface of the joint-ward end is coated with hydroxyapatite. The first section and second section may be reversibly attached or fused together.
These and other features, aspects and advantages of the present invention will become better understood with regard to the following description, appended claims, and accompanying figures where:
According to one embodiment of the present invention, there is provided a device for ameliorating joint conditions and diseases. According to another embodiment of the present invention, there is provided a method for ameliorating a joint condition or disease in a patient. In one embodiment, the method comprises providing a device according to the present invention. The device and methods will now be disclosed in detail.
As used in this disclosure, except where the context requires otherwise, the term “comprise” and variations of the term, such as “comprising,” “comprises” and “comprised” are not intended to exclude other additives, components, integers or steps.
As used in this disclosure, except where the context requires otherwise, the method steps disclosed and shown are not intended to be limiting nor are they intended to indicate that each step is essential to the method or that each step must occur in the order disclosed but instead are exemplary steps only.
All dimensions specified in this disclosure are by way of example only and are not intended to be limiting, except where the context requires otherwise. Further, the proportions shown in these Figures are not necessarily to scale. As will be understood by those with skill in the art with reference to this disclosure, the actual dimensions and proportions of any device or part of a device disclosed in this disclosure will be determined by its intended use.
According to one embodiment of the present invention, there is provided a device for ameliorating joint conditions and diseases. Referring now to
The first section 12 of the device 10 comprises a joint-ward end 16, an opposing mating end 18, and a lateral wall 20 extending between the joint-ward end 16 and the mating end 18. The first section 12 further comprises a diameter (d-d) and an axial length (b-b). In one embodiment, the diameter (d-d) is between 5 mm and 30 mm. In another embodiment, the diameter (d-d) is between 5 mm and 20 mm. In another embodiment, the diameter (d-d) is between 8 mm and 16 mm. In a preferred embodiment, the diameter (d-d) is 8 mm. In another preferred embodiment, the diameter (d-d) is 12 mm. In another preferred embodiment, the diameter (d-d) is 16 mm. In one embodiment, the axial length (b-b) is between 0.5 mm and 2.5 mm. In another embodiment, the axial length (b-b) is between 1 mm and 2 mm. In a preferred embodiment, the axial length (b-b) is 1.25 mm.
In one embodiment, the first section 12 further comprises a peripheral column 22 partially forming the lateral wall 20, a central column 24, and three or more than three struts 26, each strut 26 extending between and connecting the peripheral column 22 and the central column 24, and each strut 26 thereby supporting the central column 24.
In one embodiment, the joint-ward end 16 further comprises a plurality of fenestrations 28, where each fenestration 28 is formed by a confluence of the peripheral column 22, the central column 24, and two adjacent struts 26 of the three or more than three struts 26. Each fenestration 28 can comprise any shape suitable for the intended purpose of the device 10, as will be understood by those with skill in the art with respect to this disclosure. In one embodiment, as shown particularly in
The first section 12 further comprises a central aperture 30 within and formed by the central column 24. The central aperture 30 can extend axially completely through the joint-ward end 16 as shown particularly in
In one embodiment, as shown in
In one embodiment, peripheral column 22 of the first section 12 comprises one or more than one notch 34 as seen in
The joint-ward end 16 of the first section 12 of the device 10 performs a partial load-bearing function after implantation, and comprises a shape suitable to substantially match the shape of the articulation surface that the device 10 recreates on the bone after implantation, as will be understood by those with skill in the art with respect to this disclosure. Therefore, the joint-ward end 16 can have either a convex profile as seen on a cross-sectional, lateral perspective view, as shown in
The lateral wall 20 of the first section 12 can be any shape suitable for the intended purpose of the device 10, as will be understood by those with skill in the art with respect to this disclosure. In a preferred embodiment, the lateral wall 20 of the first section 12 comprises a generally convex profile as seen on a cross-sectional, lateral perspective view, as shown in
The device 10 further comprises a second section 14. The second section 14 of the device 10 comprises a mating end 36, an opposing leading end 38, and a lateral wall 40 extending between the mating end 36 and the leading end 38. The second section 14 further comprises an axial length (c-c). In one embodiment, the axial length (c-c) is between 5 mm and 30 mm. In another embodiment, the axial length (c-c) is between 5 mm and 20 mm. In another embodiment, the axial length (c-c) is between 6 mm and 15 mm. In a preferred embodiment, the axial length (c-c) is 6 mm. In another preferred embodiment, the axial length (c-c) is 10 mm. In another preferred embodiment, the axial length (c-c) is 15 mm. In one embodiment, the lateral wall 40 of the second section 14 is generally cylindrical as seen in
The mating end 36 of the second section 14 of the device 10 is configured to mate with the mating end 18 of the first section 12 of the device 10. The mating end 18 of the first section 12 and the mating end 36 of the second section 14 can comprise any mating mechanism suitable for the intended purpose of the device 10 can be used, as will be understood by those with skill in the art with respect to this disclosure. In one embodiment, the mating end 18 of the first section 12 and the mating end 36 of the second section 14 mate by a suitable biocompatible adhesive, as will be understood by those with skill in the art with respect to this disclosure. In a preferred embodiment, the mating mechanism is reversible, allowing an interchange of an alternate first section 12 to a specific second section 14 so that the device 10 can be reconfigured as needed for contouring to a particular joint surface, thereby decreasing the number of second sections 14 that need to be stored on site, as will be understood by those with skill in the art with respect to this disclosure. In one embodiment, the mating end 18 of the first section 12 and the mating end 36 of the second section 14 mate by a reversible twist locking mechanism, as will be understood by those with skill in the art with respect to this disclosure. In another embodiment, the first section 12 and the second section 14 are made as a unified whole as shown in
The leading end 38 of the second section 14 of the device 10 is configured to place the device 10 into a prepared space made according to a method according to the present invention. In one embodiment, the leading end 38 comprises a scalloped edge 42. In another embodiment, the leading end 38 comprises bevels 44. In a preferred embodiment, the leading end 38 comprises both a scalloped edge 42 and bevels 44 as shown particularly in
The lateral wall 40 of the second section 14 of the device 10 extends between the mating end 36 and the leading end 38. The lateral wall 40 of the second section 14 comprises threads 46 for anchoring the device 10 within the bone. In one embodiment, the lateral wall 40 of the second section 14 further comprises a plurality of fenestrations 48 between the threads 46. In a preferred embodiment, the device 10 further comprises a plurality of fenestrations 50 formed by a confluence of the mating end 18 of the first section 12 and the mating end 36 of the second section 14. Each fenestration 48, 50 can comprise any shape suitable for the intended purpose of the device 10, as will be understood by those with skill in the art with respect to this disclosure. In a preferred embodiment, each fenestration 48, 50 is oval or round. In one embodiment, the lateral wall 40 of the second section 14 is textured to promote bony ingrowth after implantation, as will be understood by those with skill in the art with respect to this disclosure.
The first section 12 and the second section 14 can comprise any material suitable for the intended purpose of the device 10, as will be understood by those with skill in the art with respect to this disclosure. In one embodiment, the first section 12 comprises a material selected from the group consisting of a biocompatible plastic, a biocomposite polymer, a metal and a metal alloy. In one embodiment, the first section 12 comprises a material selected from the group consisting of carbon fiber, cobalt chrome, nitinol, polycaprolactone (PCL), polyether-ether-ketone (PEEK), tantalum and titanium. In one embodiment, the second section 14 comprises a material selected from the group consisting of a biocompatible plastic, a biocomposite polymer, a metal and a metal alloy. In one embodiment, the second section 14 comprises a material selected from the group consisting of carbon fiber, cobalt chrome, nitinol, polycaprolactone (PCL), polyether-ether-ketone (PEEK), tantalum and titanium. In one embodiment, the first section 12 comprises a first material and the second section 14 comprises a second material, where the first material and the second material are the same material. In another embodiment, the first section 12 comprises a first material and the second section 14 comprises a second material, where the first material and the second material are the different materials.
In one embodiment, the device 10 further comprises an insert 52. Referring now to
The device 10 can be made by any suitable method, as will be understood by those with skill in the art with respect to this disclosure. In one embodiment, the first section 12 and the second section 14 are machined from modular parts such as by direct metal laser sintering, as will be understood by those with skill in the art with respect to this disclosure.
According to another embodiment of the present invention, there is provided a method for ameliorating a joint condition or disease in a patient. Referring now to
The method comprises identifying a patient with a joint condition or disease that is suitable for treatment by the present method, where the joint comprises a bone with a surface comprising a defect caused by the joint condition or disease. As will be understood by those with skill in the art with respect to this disclosure, the joint can be any joint with a hyaline cartilage bearing surface, joint capsule, and synovial fluid. In one embodiment, the joint is a diarthrodial joint (also known as a synovial joint). In one embodiment, the joint is selected from the group consisting of an acetabulofemoral joint, an acromioclavicular joint, a femoropatellar joint, a femorotibial joint, a glenohumeral joint, a humeroradial joint, a humeroulnar joint, an interphalangeal joint, a metacarpal joint, a radioulnar joint and a talocrural joint. In one embodiment, the patient is a human. In one embodiment, the patient is a non-human animal. In a preferred embodiment, the joint condition and disease is selected from the group consisting of arthroses, chondromalacia patella, isolated chondral defect, juvenile idiopathic arthritis, ligamentous deficiency arthroses, osteoarthritis (degenerative arthritis or degenerative joint disease), osteonecrosis, osteochondritis dissecans, patellar instability, post-ligamentous injury arthritis, post-meniscectomy arthritis, post-meniscectomy arthroses, post-traumatic arthritis, rheumatoid arthritis and septic arthritis. In one embodiment, identifying the patient comprises diagnosing the patient with a joint condition and disease. In one embodiment, diagnosing the patient comprises performing one or more than one of action selected from the group consisting of performing a physical examination, performing a non-invasive imaging examination (such as magnetic resonance imaging, computerized tomography and ultrasound) and performing arthroscopy. In another embodiment, identifying the patient comprises consulting patient records to determine if the patient has a joint condition or disease suitable for treatment by the present method.
Next, the method further comprises accessing the joint 100. In one embodiment, accessing the joint 100 is accomplished by arthroscopy. In another embodiment, accessing the joint 100 is accomplished by an open surgical procedure, such as for example a mini-open procedure.
In one embodiment, as shown in
Then, the method further comprises placing a guidepin 114 within the center of the defect 102 as shown in
Next, the method further comprises creating a space 116 in the defect 102 of the bone for a device. In one embodiment, the space 116 is created using a bone reamer 118 placed over the guidepin 114 to core and plane the surface of the defect 102 as shown in
In one embodiment, the method further comprises creating one or more than one vascular channel in the bone deep to the space 116 using a drill bit guide 120 positioned over the guidepin 114 and a drill bit 122 passed within the drill bit guide 120 as shown in
Next, the method further comprises providing a first device 126 for ameliorating joint conditions and diseases suitable for ameliorating the joint condition or disease of the patient as can be seen in
In one embodiment, the method further comprises injecting a biologic material, such as for example stem cells or platelet rich plasma, or both stem cells and platelet rich plasma 130 into the first device 126 using an injector 132 as shown in
Then, the method further comprises screwing the first device 126 into the space 116 using the driver 128, as shown in
In one embodiment, as can be seen in
Under natural healing conditions without medical intervention, the cortical bone base plate 138 tends to grow past a boundary/transition 143 of the cartilage zone 139 in a direction 142 toward the articulating body joint at the injury site 141 as shown in
An embodiment of the present invention includes a new, useful and non-obvious method of facilitating cartilage regrowth and preventing bone overgrowth to a damaged bone at a treatment site within a body joint to promote healing and avoid the scenario described above and shown in
With reference to
Advantageously, the device 10 is positioned and configured to provide active or passive dampening support to the bone at the treatment/injury site 141 so as to dissipate and dampen shock within the bone to promote healing. This may prevent excessive thickening of the cancellous bone. The second section 14 includes fenestrations 48 and these fenestrations are configured to promote osseointegration of the second section at the treatment site. This provides stability. Furthermore, as discussed in U.S. Patent Application 62/260,030, entitled “Methods, Systems, and Devices for Repairing Anatomical Joint Conditions” filed on Nov. 25, 2015, which is pending, the contents of which are incorporated herein by reference, the fenestrations may have different porosities targeted to promote specific tissue growth and differentiation. For example, the fenestrations may be different sizes conducive to facilitating cartilage regrowth on outer surface 16b of the joint-ward end 16 and to prevent bone overgrowth into the cartilage zone 139 within the body joint on the inner surface 16a of the joint-ward end 16. The joint-ward end 16 may be substantially positioned at a boundary/transition area 143 between a cartilage layer and a bone layer such that cartilage can grow through and around and even over the top of the fenestrations 28 in the joint-ward end 16. The transition area 143 may be located substantially in a cortical bone base plate or located substantially between cancellous bone and a cartilage zone, for example.
The plurality of fenestrations between the protrusions (e.g. treads, notches) 46 on the second section of the lateral wall are between about 300 microns and 1200 microns in size to promote bone growth while the plurality of fenestrations on the joint-ward end of the first section are between about 100 microns to 800 microns in size to promote cartilage growth. Preferably, the plurality of fenestrations on the joint-ward end 16 of the first section are between about 400 microns to 800 microns in size to promote cartilage growth. Circular pores, pie-shaped fenestrations and other shapes are considered.
Though the method of the present invention has been disclosed with respect to a defect 102 in a femorotibial joint 100, corresponding methods can be used with other joints.
Although the present invention has been discussed in considerable detail with reference to certain preferred embodiments, other embodiments are possible. Therefore, the scope of the appended claims should not be limited to the description of preferred embodiments contained in this disclosure.
This application is a continuation of U.S. patent application Ser. No. 15/148,894, entitled “Method For Ameliorating Joint Conditions And Diseases And Preventing Bone Hypertrophy,” filed on May 6, 2016; which is a continuation-in-part of U.S. patent application Ser. No. 14/603,586, entitled “Method and Device for Ameliorating Joint Conditions and Diseases,” filed on Jan. 23, 2015, now U.S. Pat. No. 9,532,878; which is a divisional of U.S. patent application Ser. No. 13/421,792, entitled “Method and Device for Ameliorating Joint Conditions and Diseases,” filed on Mar. 15, 2012, now U.S. Pat. No. 8,968,404; which is a continuation-in-part of U.S. patent application Ser. No. 12/328,493, entitled “Joint Support and Subchondral Support System,” filed Dec. 4, 2008. U.S. patent application Ser. No. 15/148,894 also claims the benefit of and priority to U.S. Patent Application 62/260,030, entitled “Methods, Systems, and Devices for Repairing Anatomical Joint Conditions” filed on Nov. 25, 2015. The contents of each of the applications listed in this paragraph are incorporated herein by reference in their entireties.
| Number | Name | Date | Kind |
|---|---|---|---|
| 2308027 | Robinson et al. | Jan 1943 | A |
| 4055862 | Farling | Nov 1977 | A |
| 4344193 | Kenny | Aug 1982 | A |
| 4502161 | Wall | Mar 1985 | A |
| 4615705 | Scales et al. | Oct 1986 | A |
| 4654314 | Takagi et al. | Mar 1987 | A |
| 4687675 | Nakano et al. | Aug 1987 | A |
| 4728332 | Albrektsson | Mar 1988 | A |
| 4839215 | Starling et al. | Jun 1989 | A |
| 4880429 | Stone | Nov 1989 | A |
| 4919667 | Richmond | Apr 1990 | A |
| 4963145 | Takagi et al. | Oct 1990 | A |
| 5007934 | Stone | Apr 1991 | A |
| 5026373 | Ray et al. | Jun 1991 | A |
| 5171322 | Kenny | Dec 1992 | A |
| 5306311 | Stone et al. | Apr 1994 | A |
| 5344459 | Swartz | Sep 1994 | A |
| 5607474 | Athanasiou | Mar 1997 | A |
| 5865849 | Stone | Feb 1999 | A |
| 5968098 | Winslow | Oct 1999 | A |
| 5984970 | Bramlet | Nov 1999 | A |
| 6037519 | Mckay | Mar 2000 | A |
| 6042610 | Li et al. | Mar 2000 | A |
| 6046379 | Stone et al. | Apr 2000 | A |
| 6093204 | Stone | Jul 2000 | A |
| 6149651 | Drewry et al. | Nov 2000 | A |
| 6176874 | Vacanti et al. | Jan 2001 | B1 |
| 6193755 | Metz-Stavenhagen et al. | Feb 2001 | B1 |
| 6206927 | Fell et al. | Mar 2001 | B1 |
| 6251143 | Schwartz et al. | Jun 2001 | B1 |
| D450122 | Michelson | Nov 2001 | S |
| 6371958 | Overaker | Apr 2002 | B1 |
| 6520964 | Tallarida et al. | Feb 2003 | B2 |
| 6530956 | Mansmann | Mar 2003 | B1 |
| 6530958 | Cima et al. | Mar 2003 | B1 |
| 6540786 | Chibrac et al. | Apr 2003 | B2 |
| 6562071 | Järvinen | May 2003 | B2 |
| 6575986 | Overaker | Jun 2003 | B2 |
| 6579293 | Chandran | Jun 2003 | B1 |
| 6585770 | White et al. | Jul 2003 | B1 |
| 6629997 | Mansmann | Oct 2003 | B2 |
| 6645251 | Salehi et al. | Nov 2003 | B2 |
| 6699252 | Farr, II et al. | Mar 2004 | B2 |
| 6712822 | Re et al. | Mar 2004 | B2 |
| 6758865 | Stone et al. | Jul 2004 | B1 |
| 6761739 | Shepard | Jul 2004 | B2 |
| 6783550 | MacArthur | Aug 2004 | B2 |
| 6793676 | Plouhar et al. | Sep 2004 | B2 |
| 6855165 | Fell et al. | Feb 2005 | B2 |
| 6911044 | Fell et al. | Jun 2005 | B2 |
| 6923831 | Fell et al. | Aug 2005 | B2 |
| 6994730 | Posner | Feb 2006 | B2 |
| 7066961 | Michelson | Jun 2006 | B2 |
| 7282063 | Cohen et al. | Oct 2007 | B2 |
| 7291169 | Hodorek | Nov 2007 | B2 |
| 7297161 | Fell | Nov 2007 | B2 |
| 7338524 | Fell et al. | Mar 2008 | B2 |
| 7608105 | Pavlov et al. | Oct 2009 | B2 |
| 7641694 | Goble et al. | Jan 2010 | B1 |
| 8480757 | Gage et al. | Jul 2013 | B2 |
| 8556972 | Gordon et al. | Oct 2013 | B2 |
| 8591592 | Dreyfuss | Nov 2013 | B2 |
| 8753401 | Dee | Jun 2014 | B2 |
| 8968404 | Dee | Mar 2015 | B2 |
| 10610364 | Dee | Apr 2020 | B2 |
| 10792130 | Solèr et al. | Oct 2020 | B2 |
| 11039927 | Dee et al. | Jun 2021 | B2 |
| 20010039455 | Simon | Nov 2001 | A1 |
| 20020010511 | Michelson | Jan 2002 | A1 |
| 20020055783 | Tallarida | May 2002 | A1 |
| 20020120270 | Trieu et al. | Aug 2002 | A1 |
| 20020120274 | Overaker | Aug 2002 | A1 |
| 20020173855 | Mansmann | Nov 2002 | A1 |
| 20030007957 | Britton et al. | Jan 2003 | A1 |
| 20030040798 | Michelson | Feb 2003 | A1 |
| 20030083665 | Re et al. | May 2003 | A1 |
| 20030109928 | Pasquet et al. | Jun 2003 | A1 |
| 20040006393 | Burkinshaw | Jan 2004 | A1 |
| 20040133275 | Mansmann | Jul 2004 | A1 |
| 20040199250 | Fell | Oct 2004 | A1 |
| 20040230315 | Ek | Nov 2004 | A1 |
| 20040243250 | Stone et al. | Dec 2004 | A1 |
| 20050004572 | Biedermann et al. | Jan 2005 | A1 |
| 20050033424 | Fell | Feb 2005 | A1 |
| 20050043813 | Kusanagi et al. | Feb 2005 | A1 |
| 20050055101 | Sifneos | Mar 2005 | A1 |
| 20050060037 | Michelson | Mar 2005 | A1 |
| 20050164146 | Cantor | Jul 2005 | A1 |
| 20050171604 | Michalow | Aug 2005 | A1 |
| 20050209703 | Fell | Sep 2005 | A1 |
| 20050221703 | Stone | Oct 2005 | A1 |
| 20050234549 | Kladakis et al. | Oct 2005 | A1 |
| 20050266383 | Aravena | Dec 2005 | A1 |
| 20050267584 | Burdulis, Jr. et al. | Dec 2005 | A1 |
| 20050278025 | Ku et al. | Dec 2005 | A1 |
| 20060141012 | Gingras | Jun 2006 | A1 |
| 20060155287 | Montgomery et al. | Jul 2006 | A1 |
| 20060173542 | Shikinami | Aug 2006 | A1 |
| 20060190078 | Fell | Aug 2006 | A1 |
| 20060224244 | Thomas et al. | Oct 2006 | A1 |
| 20070005143 | Ek et al. | Jan 2007 | A1 |
| 20070078518 | Lavi | Apr 2007 | A1 |
| 20070128575 | Trieu | Jun 2007 | A1 |
| 20070179610 | Biedermann et al. | Aug 2007 | A1 |
| 20070244565 | Stchur | Oct 2007 | A1 |
| 20070299450 | Her et al. | Dec 2007 | A1 |
| 20080051796 | Nycz et al. | Feb 2008 | A1 |
| 20080077248 | Murillo et al. | Mar 2008 | A1 |
| 20080114400 | Dant et al. | May 2008 | A1 |
| 20080125863 | McKay | May 2008 | A1 |
| 20080154266 | Protopsaltis et al. | Jun 2008 | A1 |
| 20080154314 | McDevitt | Jun 2008 | A1 |
| 20080249577 | Dreyfuss | Oct 2008 | A1 |
| 20080249632 | Stone | Oct 2008 | A1 |
| 20080255676 | Semler | Oct 2008 | A1 |
| 20080262616 | McKay | Oct 2008 | A1 |
| 20080269747 | Justin | Oct 2008 | A1 |
| 20090024229 | Chen et al. | Jan 2009 | A1 |
| 20090143867 | Gage et al. | Jun 2009 | A1 |
| 20090276053 | Brown et al. | Nov 2009 | A1 |
| 20090298777 | McKay | Dec 2009 | A1 |
| 20090319045 | Truncale | Dec 2009 | A1 |
| 20100082491 | Rosenblatt et al. | Apr 2010 | A1 |
| 20100145451 | Dee | Jun 2010 | A1 |
| 20100160984 | Berry et al. | Jun 2010 | A1 |
| 20100168856 | Long et al. | Jul 2010 | A1 |
| 20100278891 | Ringeisen | Nov 2010 | A1 |
| 20110009964 | Schwartz et al. | Jan 2011 | A1 |
| 20110029081 | Malone | Feb 2011 | A1 |
| 20110054529 | Michelson | Mar 2011 | A1 |
| 20110125264 | Bagga et al. | May 2011 | A1 |
| 20110137352 | Biedermann et al. | Jun 2011 | A1 |
| 20120172880 | Dee | Jul 2012 | A1 |
| 20120185044 | Dee | Jul 2012 | A1 |
| 20120316513 | Sharkey et al. | Dec 2012 | A1 |
| 20130035764 | Sharkey et al. | Feb 2013 | A1 |
| 20140350678 | Dee | Nov 2014 | A1 |
| 20140379032 | Hennard | Dec 2014 | A1 |
| 20150142121 | Dee | May 2015 | A1 |
| 20160250026 | Dee | Sep 2016 | A1 |
| 20170325914 | Tushtev et al. | Nov 2017 | A1 |
| 20190076257 | Dee | Mar 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 102085114 | Jun 2011 | CN |
| 102281838 | Nov 2014 | CN |
| 104271055 | Jan 2015 | CN |
| 1129675 | Sep 2001 | EP |
| 739631 | Mar 2003 | EP |
| 1541095 | Jun 2005 | EP |
| 2329781 | Jun 2011 | EP |
| 1719532 | Jul 2011 | EP |
| 2174674 | Jan 2012 | EP |
| 2308027 | Apr 2013 | EP |
| 2621411 | Aug 2013 | EP |
| 2825113 | Jan 2015 | EP |
| 2825113 | Oct 2015 | EP |
| 2825113 | Apr 2018 | EP |
| 2236679 | Apr 1991 | GB |
| 1164682 | Jul 2015 | HK |
| 10504217 | Apr 1998 | JP |
| 2001293003 | Oct 2001 | JP |
| 2007532149 | Nov 2007 | JP |
| 2008539814 | Nov 2008 | JP |
| 2015511858 | Apr 2015 | JP |
| 2146503 | Mar 2000 | RU |
| 2161929 | Jan 2001 | RU |
| 171836 | Jul 2011 | SG |
| 9624302 | Aug 1996 | WO |
| 9841246 | Sep 1998 | WO |
| 0139694 | Jun 2001 | WO |
| 03007879 | Jan 2003 | WO |
| 2005084216 | Sep 2005 | WO |
| 2006119126 | Nov 2006 | WO |
| 2007007106 | Jan 2007 | WO |
| 2008016862 | Feb 2008 | WO |
| 2010065426 | Jun 2010 | WO |
| 2010144065 | Dec 2010 | WO |
| 2013137889 | Sep 2013 | WO |
| 2016062307 | Apr 2016 | WO |
| 2017091657 | Jun 2017 | WO |
| Entry |
|---|
| U.S. Appl. No. 12/328,493, Advisory Action dated Nov. 30, 2011, 3 pages. |
| U.S. Appl. No. 12/328,493, Final Office Action dated Sep. 16, 2011, 16 pages. |
| U.S. Appl. No. 12/328,493, Non-Final Office Action dated Apr. 7, 2011, 11 pages. |
| U.S. Appl. No. 12/328,493, Restriction Requirement dated Feb. 10, 2011, 9 pages. |
| U.S. Appl. No. 13/420,825, Final Office Action dated Oct. 24, 2013, 13 pages. |
| U.S. Appl. No. 13/421,792, Notice of Allowance dated Oct. 27, 2014, 11 pages. |
| U.S. Appl. No. 13/421,792, Restriction Requirement dated Jan. 16, 2014, 6 pages. |
| U.S. Appl. No. 14/279,453, Final Office Action dated Mar. 5, 2015, 11 pages. |
| U.S. Appl. No. 14/279,453, Non Final Office Action dated Oct. 23, 2014, 12 pages. |
| U.S. Appl. No. 14/279,453, Notice of Allowance dated Jun. 5, 2015, 9 pages. |
| U.S. Appl. No. 14/603,586, Final Office Action dated May 5, 2016, 12 pages. |
| U.S. Appl. No. 14/603,586, Non-Final Office Action dated Nov. 10, 2015, 9 pages. |
| U.S. Appl. No. 14/603,586, Notice of Allowance dated Aug. 29, 2016, 9 pages. |
| U.S. Appl. No. 15/148,894, Final Office Action dated Apr. 12, 2019, 15 pages. |
| U.S. Appl. No. 15/148,894, Non-Final Office Action dated Aug. 1, 2018, 13 pages. |
| U.S. Appl. No. 15/148,894, Non-Final Office Action dated Jul. 13, 2017, 9 pages. |
| Australian Patent Application No. 2012373272, First Examiner Report dated Sep. 29, 2016, 3 pages. |
| Chinese Patent Application No. 201080004557.2, Office Action dated Jun. 20, 2013, 11 pages. |
| Chinese Patent Application No. 201280072377.7, Office Action dated Feb. 2, 2016, 14 pages. |
| Chinese Patent Application No. 201280072377.7, Office Action dated Sep. 29, 2016, 17 pages. |
| European Patent Application No. 09830912.3, Extended European Search Report dated Jul. 28, 2014, 10 pages. |
| European Patent Application No. 12871086.0, Extended European Search Report dated Sep. 23, 2015, 7 pages. |
| Japanese Patent Application No. 2015-500409, Notice of Allowance dated Aug. 30, 2016, 3 pages. |
| Japanese Patent Application No. 2015-500409, Office Action dated Dec. 25, 2015, 9 pages. |
| Leslie et al., “A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling”, Nature Biotechnology, vol. 32, 2014, pp. 1134-1140. |
| Mrosek et al., “Porous Tantalum and Poly-E-Caprolactone Biocomposites for Osteochondral Defect Repair: Preliminary Studies in Rabbits', Orthopaedic Research Society”, Journal of Orthopaedic Research, Feb. 2010, pp. 141-148. |
| International Patent Application No. PCT/US2009/065993, International Search Report and Written Opinion dated Aug. 13, 2010, 15 pages. |
| International Patent Application No. PCT/US2012/029291, International Preliminary Report on Patentability dated Sep. 25, 2014, 8 pages. |
| International Patent Application No. PCT/US2012/029291, International Search Report and Written Opinion dated Jul. 13, 2012, 9 pages. |
| Roemer et al., “Long-term osseous sequelae after acute trauma of the knee joint evaluated by MRI”, Skeletal Radial., vol. 31, 2002, pp. 615-623. |
| Orth et al., “Alterations of the Subchondral Bone in Osteochondral Repair—Translational Data and Clinical Evidence”, European Cells and Materials, vol. 25, 2013, pp. 299-316. |
| U.S. Appl. No. 15/778,196 , “Non-Final Office Action”, dated Aug. 19, 2020, 29 pages. |
| U.S. Appl. No. 15/778,196 , “Notice of Allowance”, dated Feb. 4, 2021, 18 pages. |
| Lewis , “Practical Haematology”, Churchill Livingstone Elsevier, 2006, 14 pages. |
| PCT/US2016/063481 , “International Search Report and Written Opinion”, dated Apr. 12, 2017, 25 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20200330234 A1 | Oct 2020 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62260030 | Nov 2015 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 13421792 | Mar 2012 | US |
| Child | 14603586 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15148894 | May 2016 | US |
| Child | 16840132 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 14603586 | Jan 2015 | US |
| Child | 15148894 | US | |
| Parent | 12328493 | Dec 2008 | US |
| Child | 13421792 | US |
